Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Turcot syndrome × Celecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 22 Breast Neoplasms 19 Carcinoma, Non-Small-Cell Lung 17 Lung Neoplasms 14 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Colonic Neoplasms 9 Prostatic Neoplasms 8 Pancreatic Neoplasms 6 Mouth Neoplasms 6 Glioblastoma 6 Neoplasm Metastasis 5 Esophageal Neoplasms 5 Central Nervous System Neoplasms 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Recurrence 4 Precancerous Conditions 4 Ovarian Neoplasms 4 Neuroblastoma 4 Gliosarcoma 4 Carcinoma 4 Adenomatous Polyposis Coli 4 Sarcoma 3 Oropharyngeal Neoplasms 3 Neoplasms 3 Laryngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Glioma 3 Carcinoma, Hepatocellular 3

Interventions

pembrolizumab 4 Nivolumab 3 sintilimab 2 Neoadjuvant Therapy 2 toripalimab 1 tislelizumab 1 spartalizumab 1 relatlimab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 denileukin diftitox 1 danvatirsen 1 avelumab 1 atezolizumab 1 Taxes 1 Surgical Procedures, Operative 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Ipilimumab 1 Induction Chemotherapy 1 Immunotherapy 1 Immunoglobulin G 1 Immune Checkpoint Inhibitors 1 IMM-101 1 E7777 fusion protein 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03926338 2025-11-20

PICC

Sun Yat-sen University

Phase 2 Recruiting

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡